Screener
LeMaitre Vascular LMAT Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by LeMaitre Vascular in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: LeMaitre Vascular’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333762
| Line item | For the six months ended / June 30, 2026 | For the six months ended / June 30, 2025 |
|---|---|---|
| Purchases of property and equipment | (5,096) | (2,725) |
| Payments related to acquisitions, net of cash acquired | (158) | (95) |
| Proceeds from short-term marketable securities | 212,489 | — |
| Net cash used in investing activities | (24,199) | (20,669) |
| Financing activities | ||
| Proceeds from stock option exercises | 3,728 | 3,072 |
| Deferred payments for acquisitions | (95) | (1,433) |
| Payment of withholding taxes in connection with net settlement of equity awards | (477) | (605) |
Item 1. Financial Statements
FAQ
- What is LeMaitre Vascular's investing cash flow?
- LeMaitre Vascular (LMAT) reported investing cash flow of -$11.08M in Q2 2026.
- How has LeMaitre Vascular's investing cash flow changed year-over-year?
- LeMaitre Vascular's investing cash flow increased by 32.2% year-over-year, from -$16.35M to -$11.08M.
- What is the long-term trend for LeMaitre Vascular's investing cash flow?
- Over 3 years (2022 to 2025), LeMaitre Vascular's investing cash flow has grown at a 84.3% compound annual growth rate (CAGR), from -$10.37M to -$64.94M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about LeMaitre Vascular's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude